Skip to main content
Brandon Smaglo, MD, Oncology, Houston, TX

Brandon George Smaglo MD FACP

Gastrointestinal Cancer, Hematologic Oncology


Associate Professor at MD Anderson Cancer Center

Join to View Full Profile
  • 1515 Holcombe Blvd Ste 1350Houston, TX 77030

  • Phone+1 713-792-6161

Dr. Smaglo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Clinical focus on the management of pancreatic and other gastrointestinal cancers.

    Research focuses are on the development of clinical and translational studies of all phases in pancreatic cancer.
  • Immune Cell Therapy Shows Early Promise for Patients With Pancreatic Cancer

    SAN FRANCISCO - A nonengineered, multiantigen-specific T-cell therapy was safe, tolerable, and showed signs of clinical activity in patients who had pancreatic

Education & Training

  • Rice University Jones School of Business
    Rice University Jones School of BusinessGraduate Certificate, Healthcare Management, 2018 - 2019
  • MedStar Health Georgetown University
    MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityChief Residency, Internal Medicine, 2009 - 2010
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2006 - 2009
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2006
  • Vassar College
    Vassar CollegeAB, Biochemistry, Departmental Honors, 1998 - 2002

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • WA State Medical License
    WA State Medical License 2022 - 2027
  • AZ State Medical License
    AZ State Medical License 2022 - 2026
  • GA State Medical License
    GA State Medical License 2022 - 2026
  • LA State Medical License
    LA State Medical License 2022 - 2026
  • TN State Medical License
    TN State Medical License 2022 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Oncology Faculty Educator of the Year Baylor College of Medicine Graduating Fellows, 2017
  • Teacher of the Year Georgetown University Hospital Graduating Fellows, 2016
  • Fellow American College of Physicians, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Targeting pancreatic cancer using nonengineered, multiantigen specific T cells (TACTOPS) 
    AACR Immune Cell Therapies for Cancer meeting, San Francisco, CA - 7/20/2019
  • Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemoradiation Therapy for Locally Advanced Esophageal Cancer -AND- Who Benefits from Adjuvant Therapy following Neoa... 
    Current Medical and Surgical Management of Esophageal Diseases Meeting
  • State-of-the-Art Medical Management of Colorectal Cancer 
    Baylor St Luke’s Medical Center Oncology Grand Rounds, - 3/20/2017
  • Join now to see all

Press Mentions

  • AACR: Researchers Share Promising Results from MD Anderson Clinical Trials
    AACR: Researchers Share Promising Results from MD Anderson Clinical TrialsApril 25th, 2025
  • Pancreatic Cancer Treatment at MD Anderson Gave Me Hope
    Pancreatic Cancer Treatment at MD Anderson Gave Me HopeNovember 29th, 2022
  • Marker Therapeutics Reports Interim Results of Its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
    Marker Therapeutics Reports Interim Results of Its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual MeetingMay 29th, 2020
  • Join now to see all

Committees

  • Cancer Liaison Physician, Committee on Cancer, Baylor St Luke's Medical Center 2017 - Present
  • Member representing Dan L Duncan Comprehensive Cancer Center, Faculty Inclusion Ambassador 2016 - Present
  • Co-Moderator, Neuroendocrine tumor board 2016 - Present
  • Member, Adult Working Group of Protocol Review and Monitoring Committee 2016 - Present
  • member, IRB (Georgetown) 2014 - 2016

Professional Memberships

Industry Relationships

  • Speaker's Bureau, Taiho Oncology2017 - Present

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: